The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Colombel, Jean-Frédéric
The safety of vedolizumab for ulcerative colitis and Crohn's disease. [electronic resource] - Gut 05 2017 - 839-851 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1468-3288
10.1136/gutjnl-2015-311079 doi
Adrenal Cortex Hormones--therapeutic use
Adult
Age Factors
Antibodies, Monoclonal, Humanized--adverse effects
Antibodies, Neutralizing--blood
Chemical and Drug Induced Liver Injury--epidemiology
Clostridium Infections--epidemiology
Colitis, Ulcerative--drug therapy
Crohn Disease--drug therapy
Female
Gastrointestinal Agents--adverse effects
Humans
Incidence
Infusions, Intravenous--adverse effects
Leukoencephalopathy, Progressive Multifocal--epidemiology
Male
Middle Aged
Narcotics--therapeutic use
Neoplasms--epidemiology
Randomized Controlled Trials as Topic
Risk Factors
Sepsis--epidemiology
Treatment Failure
Tuberculosis--epidemiology
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult
The safety of vedolizumab for ulcerative colitis and Crohn's disease. [electronic resource] - Gut 05 2017 - 839-851 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1468-3288
10.1136/gutjnl-2015-311079 doi
Adrenal Cortex Hormones--therapeutic use
Adult
Age Factors
Antibodies, Monoclonal, Humanized--adverse effects
Antibodies, Neutralizing--blood
Chemical and Drug Induced Liver Injury--epidemiology
Clostridium Infections--epidemiology
Colitis, Ulcerative--drug therapy
Crohn Disease--drug therapy
Female
Gastrointestinal Agents--adverse effects
Humans
Incidence
Infusions, Intravenous--adverse effects
Leukoencephalopathy, Progressive Multifocal--epidemiology
Male
Middle Aged
Narcotics--therapeutic use
Neoplasms--epidemiology
Randomized Controlled Trials as Topic
Risk Factors
Sepsis--epidemiology
Treatment Failure
Tuberculosis--epidemiology
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult